Free uk delivery on all of our products    we ship worldwide for £6.95

Blog

ARTICLES,REVIEWS AND ADVICE ON ALL THE LATEST SKINCARE PRODUCTS AND TREATMENTS

A Study – Using Sebclair for Treatment of seborrhoeic dermatitis

17th February, 2020 by Andrea

Treatment of mild to moderate seborrhoeic dermatitis with MAS064D (Sebclair), a novel topical medical device: results of a pilot, randomized, double-blind, controlled trial.

Veraldi S, Menter A, Innocenti M.

Author information
Institute of Dermatological Sciences, University of Milan, IRCCS Foundation, Policlinico, Mangiagalli, Italy. stefano.veraldi@unimi.it

Abstract

AIM:

MAS064D (Sebclair) is a novel steroid-free cream containing multiple active ingredients. Objective of this pilot study was to evaluate the efficacy and safety of MAS064D in the treatment of mild to moderate SD of the face.

METHODS:

Patients (n = 60) with SD were randomized to receive MAS064D (n = 40) or a matching vehicle (n = 20). The primary study endpoint was investigators’ global assessment (IGA) score at day 28, compared with baseline. Secondary endpoints included: IGA score at day 14; investigators’ assessment of erythema and scaling; patients’ assessment of burning/stinging, pruritus and global response to MAS064D; resort to rescue medication; quality of life.

RESULTS:

Use of MAS064D for 4 weeks was associated with a higher percentage of success in the MAS064D group than in the vehicle group (approximately 68% vs 11%, P < 0.0001). The effects of MAS064D were significantly better than those of vehicle for investigator-assessed erythema and scaling, and patients’ assessed pruritus and global response to MAS064D (P 0.01). No patient in the MAS064D group required rescue medication, compared with two patients in the vehicle group. Four patients (two each in the MAS064D and vehicle groups) reported a total of six non-serious adverse events.

CONCLUSIONS:

MAS064D appears to be an effective and well tolerated cream for the treatment of mild to moderate SD of the face. Further clinical evaluation of MAS064D in SD is warranted.

Comment in

Qualitative, not quantitative, alterations of sebum important in seborrhoeic dermatitis. [J Eur Acad Dermatol Venereol. 2009]

click here to view the study

Sebclair® is a non-steroidal range of clinically proven products now available at Dermacare Direct

Welcome to the Dermacare Direct skincare blog…   Here you can gain an insight into professional skincare regimes, products & devices. Andrea and her team of experts provide practical advice and professional tips on a range of skincare issues – ageing, acne, scars, troubled skin & many more interesting topics about your skin

Follow Us

Related Posts

Colorescience Tint Du Soleil SPF30 Whipped Foundation – Product Review

22nd May, 2020

Colorescience Tint Du Soleil SPF 30 Nourish and even your complexion with Colorescience® Tint du Soleil™ UV Protective Whipped Foundation…. Read More

Colorescience Total Shield SPF 50 – New Colours

20th May, 2020

Face Shield is now available in 3 flawless finishes, all with hydrating, antioxidant-rich mineral formulas and broad-spectrum SPF 50 to… Read More

MZ Tint & Protect Skin Perfecting SPF 30 – New Product

18th May, 2020

This lightweight SPF 30, tinted daytime moisturiser is activated by a high molecular weight Hyaluronic Acid, Kahai Nut Oil and… Read More